Oncology
News
Drugs
Xagena Medicine
Xagena.net
Ovary removal surgery increases risk for dementia
Nanoparticles show promise in reducing radiation side effects
Signaling proteins may represent biomarkers for melanoma
Vegetables inhibit growth of prostate cancer in mice with human tumors
Ginkgo biloba extract inhibits growth of breast tumor in mouse model
Androgen deprivation therapy does not keep localized prostate cancer from spreading
Hepatic arterial infusion therapy improves survival for patients with colorectal cancer
Metastatic melanoma cells are reprogrammed in embryonic environment
Combined CHOP and HAART therapy improves AIDS-related lymphoma outcome
Atomic bomb survivors who had higher radiation exposure show increased incidence of thyroid diseases
Delayed intervention may combat overtreatment of prostate cancer
Depomedroxyprogesterone is effective treatment for hot flashes
Calcitriol reduces thrombosis in cancer patients
Lung cancer: Bortezomib extends survival 22 percent
Early breast cancer: better survival seen for patients switched from Tamoxifen to Exemestane
Apo2L selectively activates death receptors in cancer cells
Childhood cancer: polymorphisms in GSTP gene increase risk for congestive heart failure after treatment with anthracyclines
Sutent shows promise in children with metastatic GIST resistant to Imatinib
Advanced kidney cancer: Sutent shows significant benefits over Interferon-alpha
Head and neck cancer: Docetaxel combined with standard chemotherapy reduces mortality by nearly 30 percent
Breast cancer: Vitamin D and Calcium supplements have varied effects
HER-2 positive breast cancer: Herceptin added to radiation therapy
Brain metastases: Xcytrin extends cognitive function
Lung cancer: disease control rate may be a more powerful predictor of survival than tumor shrinkage
Preventive surgery reduces the risk of BRCA breast and ovarian cancers
Lung cancer: ICAM, a new predictor for treatment response and survival
Raloxifene and Tamoxifen are both effective in reducing the risk of invasive breast cancer but have different side effects
Sunitinib is a promising drug for treatment of metastatic renal cell cancer
Brain metastases: WBRT added to focused radiotherapy may reduce the likelihood of recurrences
Gleevec attacks prostate cancer in mouse model by destroying its blood supply
Next Pages
1
2
[
3
]
4
5
6
7
8
9
10
»
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions